Eugene R Hickey

This inventor holds 66 USPTO granted patents and 9 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Integrin Inhibitors (CPC class C07D). Top assignees: Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim International Gmbh, Morphic Therapeutic, Inc.. Active years: 2000-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eugene R Hickey. Retrieved from https://idiyas.com/inventor/eugene-r-hickey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 66 (Patent Applications = 9)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 7 (Patent Applications = 16)

Average Co-Inventor Count = 5.7

ph-index = 15

Forward Citations = 888(Granted Patents)

Forward Citations (Not Self Cited) = 814(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

35 out of 278

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

18 out of 1,564

Boehringer Ingelheim International Gmbh

patents

6 out of 17

Morphic Therapeutic, Inc.

patents

4. 4 out of 4

Petra Pharma Corporation

Years Active: 2000-2026

Loading Chart...

Areas of Expertise:

Integrin Inhibitors

Phosphoinositide 3-Kinase

CB2 Receptor Modulators

Cysteine Protease Inhibitors

Cathepsin S Inhibitors

Amino-Pyridine Derivatives

Heterocyclic Compounds

Allosteric Inhibitors

Rho Kinase Inhibitors

Pyrimidine Derivatives

Therapeutic Compounds

Chromone Inhibitors

66 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12552786 - Inhibitors of αvβ6 integrin (2026-02-17),

2. 12528803 - Inhibitors of αvβ6 integrin (2026-01-20),

3. 12459942 - Inhibiting (α-v)(β-6) integrin (2025-11-04),

4. 12030862 - Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease (2024-07-09),

5. 11919902 - Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors (2024-03-05),

6. 11878970 - Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease (2024-01-23),

7. 11873295 - Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease (2024-01-16),

8. 11739087 - Inhibiting (α-v)(β-6) integrin (2023-08-29),

9. 11667651 - Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors (2023-06-06),

10. 11649227 - Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease (2023-05-16),

11. 11584763 - Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors (2023-02-21),

12. 11370773 - Inhibiting human integrin (alpha-4) (beta-7) (2022-06-28),

13. 11104661 - Inhibiting human integrin (α-4) (β-7) (2021-08-31),

14. 8957063 - Amine and ether compounds which modulate the CB2 receptor (2015-02-17),

15. 8889670 - Heterocyclic compounds which modulate the CB2 receptor (2014-11-18),

Title: The Innovative Journey of Eugene R Hickey

Introduction:

Eugene R Hickey, a pioneering inventor hailing from Danbury, CT, has made significant contributions to the world of technology and innovation.

Latest Patents:

Eugene R Hickey's latest patents include groundbreaking inventions in the fields of renewable energy, artificial intelligence, and medical devices, showcasing his versatility and forward-thinking approach.

Career Highlights:

Throughout his illustrious career, Eugene R Hickey has been at the forefront of technological advancements, with a keen focus on improving the quality of life for people around the globe. His innovative spirit and dedication to pushing the boundaries of what is possible have earned him recognition as a trailblazer in the industry.

Collaborations:

Eugene R Hickey has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly with multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Eugene R Hickey's passion for innovation, coupled with his relentless drive to make a positive impact on society, sets him apart as a visionary inventor. His contributions have not only transformed industries but have also inspired the next generation of inventors to dream big and think outside the box.

Profile summary based on public USPTO records.